CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- 8-K Event Regulation FD disclosure
- 4 Grant or award Director acquired 2,091 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 694 shares (grant or award)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 424B7 Offering Prospectus
- 4 Grant or award Director acquired 19,412 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 6,472 shares (grant or award)
- 8-K Event Results of operations
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Other acquisition Director acquired 48,505 shares (other)
- 4 Grant or award Chief Executive Officer acquired 16,168 shares (grant or award)
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
Page 8 of 15 · 282 filings